These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
469 related articles for article (PubMed ID: 30592755)
1. Healthy human serum N-glycan profiling reveals the influence of ethnic variation on the identified cancer-relevant glycan biomarkers. Gebrehiwot AG; Melka DS; Kassaye YM; Rehan IF; Rangappa S; Hinou H; Kamiyama T; Nishimura SI PLoS One; 2018; 13(12):e0209515. PubMed ID: 30592755 [TBL] [Abstract][Full Text] [Related]
2. Exploring serum and immunoglobulin G N-glycome as diagnostic biomarkers for early detection of breast cancer in Ethiopian women. Gebrehiwot AG; Melka DS; Kassaye YM; Gemechu T; Lako W; Hinou H; Nishimura SI BMC Cancer; 2019 Jun; 19(1):588. PubMed ID: 31208374 [TBL] [Abstract][Full Text] [Related]
3. A comprehensive glycome profiling of Huntington's disease transgenic mice. Gizaw ST; Koda T; Amano M; Kamimura K; Ohashi T; Hinou H; Nishimura S Biochim Biophys Acta; 2015 Sep; 1850(9):1704-18. PubMed ID: 25907331 [TBL] [Abstract][Full Text] [Related]
4. A pilot study of salivary N-glycome in HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Qin Y; Zhong Y; Ma T; Zhang J; Yang G; Guan F; Li Z; Li B Glycoconj J; 2017 Aug; 34(4):523-535. PubMed ID: 28389847 [TBL] [Abstract][Full Text] [Related]
5. Identification of abnormal fucosylated-glycans recognized by LTL in saliva of HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Zhang J; Zhong Y; Zhang P; Du H; Shu J; Liu X; Zhang H; Guo Y; Jia Z; Niu L; Yang F; Li Z Glycobiology; 2019 Mar; 29(3):242-259. PubMed ID: 30535277 [TBL] [Abstract][Full Text] [Related]
6. Serum N-Glycome analysis reveals pancreatic cancer disease signatures. Vreeker GCM; Hanna-Sawires RG; Mohammed Y; Bladergroen MR; Nicolardi S; Dotz V; Nouta J; Bonsing BA; Mesker WE; van der Burgt YEM; Wuhrer M; Tollenaar RAEM Cancer Med; 2020 Nov; 9(22):8519-8529. PubMed ID: 32898301 [TBL] [Abstract][Full Text] [Related]
7. Providing Bionic Glycome as internal standards by glycan reducing and isotope labeling for reliable and simple quantitation of N-glycome based on MALDI- MS. Qin W; Zhang Z; Qin R; Han J; Zhao R; Gu Y; Pan Y; Gu J; Ren S Anal Chim Acta; 2019 Nov; 1081():112-119. PubMed ID: 31446948 [TBL] [Abstract][Full Text] [Related]
8. Glycoblotting method allows for rapid and efficient glycome profiling of human Alzheimer's disease brain, serum and cerebrospinal fluid towards potential biomarker discovery. Gizaw ST; Ohashi T; Tanaka M; Hinou H; Nishimura S Biochim Biophys Acta; 2016 Aug; 1860(8):1716-27. PubMed ID: 26968461 [TBL] [Abstract][Full Text] [Related]
9. Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression. Chen H; Deng Z; Huang C; Wu H; Zhao X; Li Y Tumour Biol; 2017 Jul; 39(7):1010428317716249. PubMed ID: 28681696 [TBL] [Abstract][Full Text] [Related]
10. High throughput quantitative glycomics and glycoform-focused proteomics of murine dermis and epidermis. Uematsu R; Furukawa J; Nakagawa H; Shinohara Y; Deguchi K; Monde K; Nishimura S Mol Cell Proteomics; 2005 Dec; 4(12):1977-89. PubMed ID: 16170054 [TBL] [Abstract][Full Text] [Related]
11. Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis. Kamiyama T; Yokoo H; Furukawa J; Kurogochi M; Togashi T; Miura N; Nakanishi K; Kamachi H; Kakisaka T; Tsuruga Y; Fujiyoshi M; Taketomi A; Nishimura S; Todo S Hepatology; 2013 Jun; 57(6):2314-25. PubMed ID: 23322672 [TBL] [Abstract][Full Text] [Related]
12. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles. Kyselova Z; Mechref Y; Kang P; Goetz JA; Dobrolecki LE; Sledge GW; Schnaper L; Hickey RJ; Malkas LH; Novotny MV Clin Chem; 2008 Jul; 54(7):1166-75. PubMed ID: 18487288 [TBL] [Abstract][Full Text] [Related]
14. Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches. Zhu J; Warner E; Parikh ND; Lubman DM Mass Spectrom Rev; 2019 May; 38(3):265-290. PubMed ID: 30472795 [TBL] [Abstract][Full Text] [Related]
15. Large-scale glycomics for discovering cancer-associated N-glycans by integrating glycoblotting and mass spectrometry. Amano M; Nishimura S Methods Enzymol; 2010; 478():109-25. PubMed ID: 20816476 [TBL] [Abstract][Full Text] [Related]
16. Use of the serum glycan state to predict ovarian cancer patients' clinical response to chemotherapy treatment. Zhao R; Lin G; Wang Y; Qin W; Gao T; Han J; Qin R; Pan Y; Sun J; Ren C; Ren S; Xu C J Proteomics; 2020 Jul; 223():103752. PubMed ID: 32209427 [TBL] [Abstract][Full Text] [Related]
17. Insights into glycan biosynthesis in chemically-induced hepatocellular carcinoma in rats: A glycomic analysis. Amin A; Bashir A; Zaki N; McCarthy D; Ahmed S; Lotfy M World J Gastroenterol; 2015 May; 21(20):6167-79. PubMed ID: 26034352 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive N-Glycome Profiling of Cells and Tissues for Breast Cancer Diagnosis. Li Q; Li G; Zhou Y; Zhang X; Sun M; Jiang H; Yu G J Proteome Res; 2019 Jun; 18(6):2559-2570. PubMed ID: 30889355 [TBL] [Abstract][Full Text] [Related]
19. Tear N-glycomics in vernal and atopic keratoconjunctivitis. Messina A; Palmigiano A; Tosto C; Romeo DA; Sturiale L; Garozzo D; Leonardi A Allergy; 2021 Aug; 76(8):2500-2509. PubMed ID: 33583051 [TBL] [Abstract][Full Text] [Related]
20. N-glycosylation of colorectal cancer tissues: a liquid chromatography and mass spectrometry-based investigation. Balog CI; Stavenhagen K; Fung WL; Koeleman CA; McDonnell LA; Verhoeven A; Mesker WE; Tollenaar RA; Deelder AM; Wuhrer M Mol Cell Proteomics; 2012 Sep; 11(9):571-85. PubMed ID: 22573871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]